Is a postpartum (after pregnancy) woman, approximately three months postpartum with a history of possible gestational diabetes mellitus (GDM), diagnosed with diabetes mellitus based on a glucose tolerance test result of 138 mg/dL at two hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No, a 2-hour glucose value of 138 mg/dL at three months postpartum does NOT meet diagnostic criteria for diabetes mellitus

This result indicates impaired glucose tolerance (prediabetes), not diabetes. The patient requires immediate intervention with lifestyle modification and/or metformin, plus lifelong diabetes screening.

Diagnostic Criteria for Postpartum Testing

When evaluating women with prior gestational diabetes at 4-12 weeks postpartum (or later, as in this case at 3 months), you must use non-pregnant diagnostic criteria 1, 2:

For diabetes diagnosis using the 75g OGTT:

  • Fasting plasma glucose ≥126 mg/dL, OR
  • 2-hour plasma glucose ≥200 mg/dL 1, 2

For impaired glucose tolerance (prediabetes):

  • 2-hour glucose 140-199 mg/dL 1, 2

This patient's 2-hour value of 138 mg/dL falls below the threshold for both diabetes (≥200 mg/dL) and impaired glucose tolerance (≥140 mg/dL), technically representing normal glucose tolerance by strict criteria. However, values in the 138-139 mg/dL range warrant close monitoring given the patient's GDM history 2.

Critical Distinction: Pregnancy vs. Postpartum Criteria

Common pitfall: Do not apply gestational diabetes diagnostic thresholds (2-hour ≥153 mg/dL) to postpartum testing 1, 3. The cutoffs are completely different:

  • During pregnancy (GDM diagnosis): 2-hour ≥153 mg/dL 1, 3
  • Postpartum (diabetes diagnosis): 2-hour ≥200 mg/dL 1, 2

Why the 75g OGTT is Mandatory Postpartum

The American Diabetes Association specifically mandates the 75g OGTT over HbA1c testing at 4-12 weeks postpartum because 2, 4:

  • Increased red blood cell turnover during pregnancy artificially lowers HbA1c values 2, 4
  • Blood loss at delivery further distorts HbA1c results 2, 4
  • OGTT is more sensitive for detecting both prediabetes and diabetes in the early postpartum period 2, 4

Immediate Management for This Patient

Even with a technically normal result, this patient requires aggressive intervention given her GDM history 2:

1. Intensive lifestyle intervention targeting weight management, Mediterranean-style diet, and moderate physical activity—this reduces diabetes risk by 72% 2

2. Consider metformin therapy, which reduces progression to diabetes by 40% over 10 years in women with prior GDM and any degree of glucose intolerance 2

3. Establish lifelong screening every 1-3 years using 75g OGTT, fasting plasma glucose, or HbA1c 1, 2, 4

Risk Context

Women with prior GDM have a 50-60% lifetime risk of developing type 2 diabetes, with risk increasing linearly: approximately 20% at 10 years, 30% at 20 years, and 50% at 40 years 2, 4. This patient's borderline result places her at particularly high risk and demands proactive management 2.

Key action point: Even though this specific value doesn't meet diabetes criteria, treat this as a critical warning sign requiring immediate preventive intervention, not reassurance 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Postpartum Testing for Resolution of Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnóstico de Diabetes Gestacional

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Postpartum Screening and Management of Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Should I be screened for Gestational Diabetes Mellitus (GDM) at 23 weeks gestation given my family history of Type 2 Diabetes Mellitus (T2DM)?
What test should be ordered for a 16-week primigravida with a BMI of 35 to screen for gestational diabetes mellitus?
How to manage a 28-week primigravida (first-time pregnant woman) at 37 weeks gestation with a random blood sugar level of 213 mg/dl at 7 am, indicating hyperglycemia?
Is a 1-hour Oral Glucose Tolerance Test (OGTT) result of 212 mg/dL at 11 weeks gestation indicative of gestational diabetes mellitus (GDM) or type 2 diabetes?
What is the management plan for a 34-week pregnant woman with gestational diabetes mellitus (GDM), oral glucose tolerance test (OGTT) result of 230 mg/dL, and significant glycosuria (urine sugar 4+), should she be admitted?
What treatment options are available for a patient with middle insomnia, characterized by waking between 2-4 AM, who has tried trazodone, quetiapine (Seroquel), melatonin, and mirtazapine?
What is the right of a participant in a research study on a new screening test, conducted by a researcher?
Can pitting edema in the lower legs be caused by non-pathological factors in a relatively healthy middle-aged or older individual?
Can cardiac MRI (Magnetic Resonance Imaging) provide accurate measurements of the aorta in patients with suspected or known aortic disease?
What diseases are associated with urticaria?
What is the best initial management approach for a patient with degenerative cervical spondylosis and paraspinal muscle spasm, experiencing mechanical and postural pain, particularly after bending and mopping, with no cord compression or significant foraminal narrowing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.